Middle East Conflict Disrupts Regional Pharma Supply Chains
Middle East conflict has closed key air hubs and forced pharma firms to reroute drugs. Experts warn that cancer drug supplies could run low within six weeks.
The escalating conflict in the Middle East is creating significant bottlenecks for the delivery of essential medicines to the Gulf region, specifically impacting the supply of cancer treatments and other pharmaceuticals that require constant refrigeration. Following military actions involving the United States, Israel, and Iran, critical air corridors have been disrupted, forcing logistics firms and pharmaceutical manufacturers to seek alternative overland routes and secondary transit hubs.
Major aviation centers in the United Arab Emirates and Qatar have faced closures due to regional strikes, halting operations at major cargo gateways in Dubai and Doha. These airports serve as vital links for global health logistics, where companies such as Deutsche Post AG manage the movement of temperature-sensitive vaccines and life-saving drugs between Europe, Africa, and Asia.
